Covered recipient · General Payments record
JOHN H MITCHELL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$8,251.50
- Reported across 416 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $812.20 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $341.14 | 9 |
| ABBVIE INC. | $170.01 | 10 |
| GlaxoSmithKline, LLC. | $145.61 | 2 |
| Amgen Inc. | $55.69 | 2 |
| Novo Nordisk AS | $37.46 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.43 | 1 |
| Acerta Pharma LLC | $23.08 | 1 |
| Antares Pharma, Inc. | $13.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.13 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105046662 | CMS |
| ABBVIE INC. | $16.08 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105046664 | CMS |
| ABBVIE INC. | $21.32 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105046666 | CMS |
| ABBVIE INC. | $15.52 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105046668 | CMS |
| ABBVIE INC. | $16.50 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105046670 | CMS |
| ABBVIE INC. | $4.30 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105046672 | CMS |
| ABBVIE INC. | $28.72 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105046674 | CMS |
| ABBVIE INC. | $27.75 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105046676 | CMS |
| ABBVIE INC. | $1.60 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105046678 | CMS |
| ABBVIE INC. | $12.09 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105046680 | CMS |
| Amgen Inc. | $23.39 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117330132 | CMS |
| Amgen Inc. | $32.30 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117330134 | CMS |
| Antares Pharma, Inc. | $13.78 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146474412 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.08 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105714696 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.43 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117921371 | CMS |
| GlaxoSmithKline, LLC. | $24.24 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116657469 | CMS |
| GlaxoSmithKline, LLC. | $121.37 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116509809 | CMS |
| Lilly USA, LLC | $25.61 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135057918 | CMS |
| Lilly USA, LLC | $19.02 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135069015 | CMS |
| Lilly USA, LLC | $27.01 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135068851 | CMS |
| Lilly USA, LLC | $34.42 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135058566 | CMS |
| Lilly USA, LLC | $27.41 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135071433 | CMS |
| Lilly USA, LLC | $32.29 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135057920 | CMS |
| Lilly USA, LLC | $17.71 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135055898 | CMS |
| Lilly USA, LLC | $32.67 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135057036 | CMS |
| Lilly USA, LLC | $125.00 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135055900 | CMS |
| Novo Nordisk Inc | $14.05 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097830405 | CMS |
| Novo Nordisk Inc | $23.41 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096598997 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.